Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023
September 13, 2023 07:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Science 37 announced today that it has been recognized in the Gartner Hype Cycle for Life Science Clinical Development, 2023. As...
Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan
September 12, 2023 07:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, today announced that it has been honored...
Science 37 to Participate in H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023 08:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the...
Science 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA Awards
August 15, 2023 07:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ is proud to announce its nomination for the...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
August 11, 2023 16:41 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2023 (GLOBE NEWSWIRE) -- August 11, 2023—Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement...
Science 37 Reports Second Quarter 2023 Financial Results
August 08, 2023 06:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the...
Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023
July 25, 2023 06:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 25, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report second quarter 2023 financial...
Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)
July 11, 2023 07:59 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ has been chosen by Synlogic, (Nasdaq:...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
July 07, 2023 16:52 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
June 09, 2023 16:51 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...